The criterion of the inhalation test to allergens at establishing specific hyposensitizing in allergic asthma. 1975

E Seropian

The experience we had in our casuistics as regards 1,000 asthmatics, demonstrates the positive inhalation test (IT) to allergens, only in about 40% of the asthmatics having positive cutaneous test (CT). The technic for determination has used the FEV1 criterion. We correlated the data of the anamnesis (A), CT and IT. The indications of allergenic etiology concerning A, have been divided into three categories: certain anamnesis (CA), suggestive anamnesis (SA) and unconclusive anamnesis (UA). At asthmatics having + CT, CA was associated to + IT in 92%, to SA in 49% and to UA in 11% of the cases. At asthmatics having --CT, CA is possibly associated to + IT, much more rarely associated to SA and not at all associated to UA. From these correlations we deduce the value of A and the fact that --IT is sometimes a false negative test. It further results that IT is not absolutely necessary in cases having CA and + CT. However, IT becomes useful in cases having CA/SA and --CT, as well as in cases having SA/UA and +CT. In 611 persons having allergic asthma lasting cures (1-6 years) of SH have been obtained successfuly in 92% and unsuccessfuly in 8% of the cases. From this total, lot 1 (437 cases) has been selected according to criterion CA/SA and +CT; lot II (130 cases) has associated in addition to criterion of selection by +IT; lot III (44 Cases) was selected with CA/SA, +CT and --IT. Although the selection has been different, the SH results have been identical. From this we infer the spheres of SH efficacy exceed the limit of every selection criterion mentioned before. Further it is to be inferred that the routine IT brings a satisfactory selection for the SH decision only in the mentioned conditions.

UI MeSH Term Description Entries
D006967 Hypersensitivity Altered reactivity to an antigen, which can result in pathologic reactions upon subsequent exposure to that particular antigen. Allergy,Allergic Reaction,Allergic Reactions,Allergies,Hypersensitivities,Reaction, Allergic,Reactions, Allergic
D003888 Desensitization, Immunologic Immunosuppression by the administration of increasing doses of antigen. Though the exact mechanism is not clear, the therapy results in an increase in serum levels of allergen-specific IMMUNOGLOBULIN G, suppression of specific IgE, and an increase in suppressor T-cell activity. Allergen Immunotherapy,Allergy Shots,Hyposensitization Therapy,Immunotherapy, Allergen,Venom Immunotherapy,Immunologic Desensitization,Therapy, Hyposensitization,Allergen Immunotherapies,Allergy Shot,Desensitizations, Immunologic,Hyposensitization Therapies,Immunologic Desensitizations,Immunotherapy, Venom,Shot, Allergy,Venom Immunotherapies
D000485 Allergens Antigen-type substances that produce immediate hypersensitivity (HYPERSENSITIVITY, IMMEDIATE). Allergen
D001249 Asthma A form of bronchial disorder with three distinct components: airway hyper-responsiveness (RESPIRATORY HYPERSENSITIVITY), airway INFLAMMATION, and intermittent AIRWAY OBSTRUCTION. It is characterized by spasmodic contraction of airway smooth muscle, WHEEZING, and dyspnea (DYSPNEA, PAROXYSMAL). Asthma, Bronchial,Bronchial Asthma,Asthmas
D012882 Skin Tests Epicutaneous or intradermal application of a sensitizer for demonstration of either delayed or immediate hypersensitivity. Used in diagnosis of hypersensitivity or as a test for cellular immunity. Skin Test,Test, Skin,Tests, Skin

Related Publications

E Seropian
January 1967, Folia allergologica,
E Seropian
August 1984, Praxis und Klinik der Pneumologie,
E Seropian
July 1982, Vestnik dermatologii i venerologii,
E Seropian
October 1983, Praxis und Klinik der Pneumologie,
E Seropian
July 1957, La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris,
Copied contents to your clipboard!